Lyceum sells Synexus to LDC
Lyceum Capital has sold its stake in clinical trial research firm Synexus to LDC in a transaction valued at £83m (€113m).
Lyceum Capital has sold its stake in clinical trial research firm Synexus to LDC in a transaction valued at £83m (€113m).